Part 5/7:
For Cassava, the company’s clinical trial results have also been met with skepticism, particularly regarding how data points and endpoints are defined and interpreted. While many have pointed to promising avenues in both companies' research, the reality often lies in how outcomes can be manipulated or misrepresented in the trials.
Leadership and Market Confidence
Leadership plays a significant role in instilling trust within the investor base. Both companies have CEOs who are noted figures (with some debate regarding personal wealth status influencing their decision-making), and this often brings a mixed bag of resilience and skepticism. When CEO involvement is seen in clinical research publications, this typically increases red flags regarding potential bias in reported results.